国产亚洲一区在线,99国产精品视频免费观看,国产91第一页,欧美aa在线观看,亚洲激情欧美激情,亚洲国产精品高清在线一区,国产精品无码久久综合网

CN / EN

News

Technoderma's Next-Generation JAK1/Tyk2 Inhibitor TDM-180935 Receives NMPA Approval for Phase I/Ia Clinical Trial Application

Release time: 2024-12-09 Article source: 特科羅

On December 9, 2024, clinical-stage biopharmaceutical company Technoderma Medicines Inc. (hereinafter referred to as "Technoderma") officially announced that its topical ointment TDM-180935, a JAK1/Tyk2 dual-target inhibitor developed for atopic dermatitis and eczema, has recently received approval from NMPA (National Medical Products Administration) of China for its Phase I/Ia clinical trial application.